Last reviewed · How we verify
NCT03371589
Intratympanic Stereoidal Injections for Facial Nerve Palsy
NA trial testing Dexamethasone in Bell Palsy in 30 participants. Status unknown.
1 January 2019
Quick facts
| Lead sponsor | Hillel Yaffe Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 February 2018 |
| Primary completion | 1 January 2019 |
| Estimated completion | 1 August 2019 |
Drugs / interventions tested
- Dexamethasone (dexamethasone) — full drug profile →
Conditions studied
- Bell Palsy — all drugs for Bell Palsy →
Sponsor
Hillel Yaffe Medical Center
Who can join
18 and older, any sex, with Bell Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bell's palsy is defined as a facial nerve palsy without any other known cause. The common practice for this disease consists of the use of oral steroids. Such treatment can cause harm to people who have disabilities or prior conditions such as pregnancies, diabetes, obesity and/or high blood pressure. While the use of intratympanic injection for sudden sensory hearing loss is well rehearsed in many practices, similar management of facial nerve palsy due to Bell's phenomenon is rare and a few researches have been conducted regarding the subject. In this research we suggest intratympanic injections for these patients as a treatment for Bell's palsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03371589
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone
Trials testing the same drug.
- NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
- NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
- NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
- NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
- NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting
Other recruiting trials for Bell Palsy
Currently open trials in the same condition.
- NCT07519421 — Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy · NA · recruiting
- NCT06778473 — Intradermal Acupuncture and Self-rehabilitation Program in Patients With Severe Bell's Palsy · NA · recruiting
- NCT06732622 — Laser Acupuncture for Idiopathic Bell's Palsy · NA · recruiting
- NCT06459830 — Mime Therapy With and Without Neural Mobilization in Bell's Palsy. · NA · recruiting
- NCT06742580 — The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients · recruiting
Other Hillel Yaffe Medical Center trials
Trials by the same sponsor.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07134985 — Pediatric Patients Who Leave the Emergency Department Without Treatment · recruiting
- NCT06927193 — Regional Analgesia at the Pediatric Emergency Department · recruiting
- NCT07233525 — Home-Based Language and Cognitive Intervention for Arab Toddlers in Israel · NA · not yet recruiting
- NCT07320339 — The Aim of the Study is to Examine the Variation in Blood Pressure Between an Optimal Measurement (According to Establis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03371589 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hillel Yaffe Medical Center
- Last refreshed: 25 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03371589.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing